Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South Africa.

Bixa Ogola Nontokozo D MatumeDenis M TebitLufuno G Mavhandu-RamarumoPascal Obong Bessong

Published in: PloS one (2024)

The UNAIDS target of 95% viral suppression in individuals under treatment was not observed after 12 months of treatment, and this was less successful for males. Adherence and drug resistance monitoring could be beneficial for individuals harbouring resistant viruses early into treatment.

Keyphrases

hiv infected
south africa
sars cov
metabolic syndrome
combination therapy
replacement therapy